<div id="readability-page-1"><div>Welldoc® Honored with 2026 Artificial Intelligence Excellence Award Third Win Reinforces Welldoc’s Leadership in Healthcare-Ready AI Welldoc®, an AI-powered health tech leader, today announced it has been named a winner in the 2026 Artificial Intelligence Excellence Awards presented by the Business Intelligence Group (BIG). The awards recognize organizations worldwide setting the standard for responsible AI with measurable, real-world impact. Welldoc was honored in the Health Product category for a third year. By combining clinical precision with regulated AI capabilities, Welldoc delivers the personalized insights necessary to empower individuals, care teams and healthcare organizations in navigating complex conditions. &#34;We are honored to be recognized for our healthcare-ready AI, which defines the standard for responsible, outcomes-driven intelligence,&#34; said Anand Iyer, Chief AI Officer at Welldoc. &#34;Our recognition as a CMS Health Tech Ecosystem early adopter further validates our commitment to establishing national benchmarks for secure, personalized interventions that move the needle on health outcomes.&#34; Welldoc is reimagining the &#34;front door&#34; of healthcare through a proprietary intelligence layer that creates a seamless experience across the entire health journey. By delivering clinically precise guidance, Welldoc enables its partners to launch differentiated, evidence-based support programs within highly regulated environments. &#34;The AI industry is evolving at an incredible pace, and it is through the vision of companies like Welldoc that we see the true power of real-world applications,&#34; said Russ Fordyce, CEO of the Business Intelligence Group. &#34;Welldoc’s work exemplifies the type of technical innovation and leadership that is essential to shaping a more efficient and intelligent future.&#34; About Welldoc Welldoc® is an AI-powered health technology leader committed to connecting people to better, more personalized cardiometabolic care. The company's digital health platform delivers a unified experience for individuals managing diabetes, obesity (including GLP-1 support), hypertension, heart failure, and complex comorbidities including diabetes in pregnancy, sleep apnea, chronic kidney disease (CKD), and metabolic dysfunction-associated steatohepatitis (MASH). The foundation of Welldoc's solution is healthcare-ready AI, a purpose-built engine grounded in unmatched clinical rigor, with 11 FDA clearances, 60 patents, and more than 100 peer-reviewed publications demonstrating clinical effectiveness and safety. The platform's architecture allows individuals to connect to over 400 devices and data sources, while also integrating seamlessly with electronic health record (EHR) systems, to enable comprehensive data interoperability across care settings. Welldoc partners across multiple healthcare sectors—including life sciences companies, health plans, health systems, and employers—to drive innovative health programs, improved patient outcomes, and reduced costs at scale. The company has been recognized as a leader in healthcare innovation, named one of TIME and Statista's World's Top HealthTech Companies and awarded &#34;Best Overall Digital Health Company&#34; by MedTech Breakthrough™ for multiple consecutive years. Welldoc is strategically aligned with federal modernization efforts, including being named an early adopter in the CMS 2025 Health Tech Ecosystem Initiative. This ensures the company’s AI-powered solutions support critical programs like the CMS Rural Health Transformation Program (RHTP) focused on rural healthcare access. For more information, visit www.welldoc.com. Follow us on LinkedIn and X. About Business Intelligence Group The Business Intelligence Group was founded with the mission of recognizing true talent and superior performance in the business world. Unlike other industry award programs, these programs are judged by business executives having experience and knowledge. The organization's proprietary and unique scoring system selectively measures performance across multiple business domains and rewards those companies whose achievements stand above those of their peers. Visit www.bintelligence.com. <img src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1tc3RyMyZzdHk9MjAyNjAzMjY5MDEwMzZyMQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1tc3RyMyZzdHk9MjAyNjAzMjY5MDEwMzZyMQ"/> Sylvia Aranda Real Chemistry Media@welldocinc.com View source version on businesswire.com: https://www.businesswire.com/news/home/20260326901036/en/</div></div>

FDHT

TDOC

遠程醫療和數字健康 ETF - GlobalX

HEAL

Welldoc® 榮獲商業智能集團頒發的 2026 年人工智能卓越獎，這是其在健康產品類別中連續第三次獲獎。這一認可突顯了 Welldoc 在醫療保健領域的人工智能領導地位，該技術結合了臨牀精確性和受監管的能力，為個人和醫療機構提供個性化的洞察。該公司旨在通過創新的、基於證據的支持項目來改善健康結果，並被認可為 CMS 健康科技生態系統倡議的早期採用者

Welldoc® 榮獲 2026 年人工智能卓越獎